Macrophage colony-stimulating factor and receptor activator NF-κB ligand fail to rescue osteoclast-poor human malignant infantile osteopetrosis in vitro
- 31 January 2002
- Vol. 30 (1) , 85-90
- https://doi.org/10.1016/s8756-3282(01)00656-1
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Transforming growth factor-β1 (TGF-β) stimulates the osteoclast-forming potential of peripheral blood hematopoietic precursors in a lymphocyte-rich microenvironmentBone, 2001
- Personal practice: Autosomal recessive osteopetrosis: diagnosis, management, and outcomeArchives of Disease in Childhood, 2000
- 1,25-Dihydroxyvitamin D3 and Prostaglandin E2 Act Directly on Circulating Human Osteoclast PrecursorsBiochemical and Biophysical Research Communications, 1999
- Vascular Endothelial Growth Factor Can Substitute for Macrophage Colony-Stimulating Factor in the Support of Osteoclastic Bone ResorptionThe Journal of Experimental Medicine, 1999
- Osteoclast Differentiation Factor (ODF) Induces Osteoclast-like Cell Formation in Human Peripheral Blood Mononuclear Cell CulturesBiochemical and Biophysical Research Communications, 1998
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- Bone marrow transplantation for autosomal recessive osteopetrosis A report from the Working Party on Inborn Errors of the European Bone Marrow Transplantation GroupThe Journal of Pediatrics, 1994
- OsteopetrosisClinical Orthopaedics and Related Research, 1993
- Skeletal dysplasia, intracerebral calcifications, optic atrophy, hearing impairment, and mental retardation: Nosology of dysosteosclerosisAmerican Journal of Medical Genetics, 1992
- Mineral metabolism in infants with malignant osteopetrosis: Heterogeneity in plasma 1,25-dihydroxyvitamin D levels and bone histologyJournal of Bone and Mineral Research, 1992